Showing results (881-890 of 928) with videos related to
Sort By:
Pageof 93
Nature Microbiology|April 8, 2026
Microbial 10-oxostearic acid protects mice against colitis via the nuclear receptor PPARαJiabao Liu, Hao Li, Yintai Tian, et al.Journal of Oncology Practice|April 10, 2019
National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion CentersJessica M Sugalski, Timothy Kubal, Daniel L Mulkerin, et al.Cellular and Molecular Gastroenterology and Hepatology|August 23, 2024
Quantifying Forms and Functions of Enterohepatic Bile Acid Pools in MiceKoichi Sudo, Amber Delmas-Eliason, Shannon Soucy, et al.Discover Nano|September 19, 2025
Plant-based synthesis of silver nanoparticles using aqueous leaf extracts of Cinchona calisaya Wedd. and Cinchona pubescens Vahl: physicochemical characterisation and biological activitiesJustin B Safari, Victoire S Ushindi, Fortunat C Andema, et al.Antimicrobial Agents and Chemotherapy|August 28, 2019
Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosaKevin M Krause, Cat M Haglund, Christy Hebner, et al.Oncogene|March 22, 2016
Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVEG Carmona, U Perera, C Gillett, et al.Journal of Medicinal Chemistry|May 26, 2023
Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) InhibitorsRichard A Hartz, Vijay T Ahuja, Guanglin Luo, et al.Journal of Medicinal Chemistry|July 16, 2015
Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted AgentsMaxine P Roberts, Vu Nguyen, Mark E Ashford, et al.European Journal of Cancer (Oxford, England : 1990)|June 8, 2019
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology GroupT Eder, A K Hess, R Konschak, et al.Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.Pageof 93